Literature DB >> 16248985

Novel progerin-interactive partner proteins hnRNP E1, EGF, Mel 18, and UBC9 interact with lamin A/C.

Nanbert Zhong1, Gabriel Radu, Weina Ju, W Ted Brown.   

Abstract

The Hutchinson-Gilford progeria syndrome (HGPS or progeria) is an apparent accelerated aging disorder of childhood. Recently, HGPS has been characterized as one of a growing group of disorders known as laminopathies, which result from genetic defects of the lamin A/C (LMNA) gene. The majority of HGPS mutant alleles involve a silent mutation, c.2063C>T resulting in G608G, that generates a cryptic splicing site in exon 11 of LMNA and consequently truncates 50 amino acids near the C-terminus of pre-lamin A/C. To explore possible mechanisms underlying the development of HGPS, we began a search for proteins that would uniquely interact with progerin (the truncated lamin A in HGPS) using a yeast two-hybrid system. Four new progerin interactive partner proteins were identified that had not been previously found to interact with lamin A/C: hnRNP E1, UBC9 (ubiquitin conjugating enzyme E2I), Mel-18, and EGF1. However, using control and progeria fibroblasts, co-immunoprecipitation studies of endogenous proteins did not show differential binding affinity compared to normal lamin A/C. Thus, we did not find evidence for uniquely interacting partner proteins using this approach, but did identify four new lamin A/C interactive partners.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16248985     DOI: 10.1016/j.bbrc.2005.10.020

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

Review 1.  Lamins at a glance.

Authors:  Chin Yee Ho; Jan Lammerding
Journal:  J Cell Sci       Date:  2012-05-01       Impact factor: 5.285

Review 2.  Causes and consequences of nuclear envelope alterations in tumour progression.

Authors:  Emily S Bell; Jan Lammerding
Journal:  Eur J Cell Biol       Date:  2016-06-25       Impact factor: 4.492

Review 3.  Mapping of protein- and chromatin-interactions at the nuclear lamina.

Authors:  Nard Kubben; Jan Willem Voncken; Tom Misteli
Journal:  Nucleus       Date:  2010-09-03       Impact factor: 4.197

4.  Possible novel roles of poly(rC)-binding protein 1 in SH-SY5Y neurocytes: an analysis using a dynamic Bayesian network.

Authors:  Li-Rong Huo; Jian-Tao Liang; Jun-Hua Zou; Lan-Ying Wang; Qi Li; Xiao-Min Wang
Journal:  Neurosci Bull       Date:  2012-06       Impact factor: 5.203

5.  Maternal PCBP1 determines the normal timing of pronucleus formation in mouse eggs.

Authors:  Zhonghua Shi; Chun Zhao; Ye Yang; Hui Teng; Ying Guo; Minyue Ma; Xuejiang Guo; Zuomin Zhou; Ran Huo; Qi Zhou
Journal:  Cell Mol Life Sci       Date:  2015-04-17       Impact factor: 9.261

Review 6.  Post-translational modifications of intermediate filament proteins: mechanisms and functions.

Authors:  Natasha T Snider; M Bishr Omary
Journal:  Nat Rev Mol Cell Biol       Date:  2014-03       Impact factor: 94.444

Review 7.  Sumoylation and human disease pathogenesis.

Authors:  Kevin D Sarge; Ok-Kyong Park-Sarge
Journal:  Trends Biochem Sci       Date:  2009-03-11       Impact factor: 13.807

Review 8.  Partners and post-translational modifications of nuclear lamins.

Authors:  Dan N Simon; Katherine L Wilson
Journal:  Chromosoma       Date:  2013-03-12       Impact factor: 4.316

9.  Interruption of progerin-lamin A/C binding ameliorates Hutchinson-Gilford progeria syndrome phenotype.

Authors:  Su-Jin Lee; Youn-Sang Jung; Min-Ho Yoon; So-Mi Kang; Ah-Young Oh; Jee-Hyun Lee; So-Young Jun; Tae-Gyun Woo; Ho-Young Chun; Sang Kyum Kim; Kyu Jin Chung; Ho-Young Lee; Kyeong Lee; Guanghai Jin; Min-Kyun Na; Nam Chul Ha; Clea Bárcena; José M P Freije; Carlos López-Otín; Gyu Yong Song; Bum-Joon Park
Journal:  J Clin Invest       Date:  2016-09-12       Impact factor: 14.808

Review 10.  Role of A-type lamins in signaling, transcription, and chromatin organization.

Authors:  Vicente Andrés; José M González
Journal:  J Cell Biol       Date:  2009-12-28       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.